Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning

NCT ID: NCT00606788

Last Updated: 2008-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-11-30

Study Completion Date

2007-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to determine whether computer-driven protocolized weaning is superior to physician-directed non-protocolized weaning in over-24-hours-ventilated surgical intensive care unit (ICU) patients. The main hypothesis was that weaning duration differs between both methods. Secondary hypotheses were that reintubation rate, duration of mechanical ventilation, intensive care unit (ICU) length of stay and workload for physicians and nurses differ between both methods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since long-term mechanical ventilation is affiliated with a bunch of complications, weaning affected patients from ventilation as soon as possible is a crucial point. In this context automated computerized systems have become a torchbearer. These systems are expected to expedite the weaning process, reduce the duration of mechanical ventilation and ICU length of stay of a given patient in comparison to conventional physician-directed weaning. A multicenter randomized trial by Lellouche et al supported these theories, using a computer-driven system to regulate Pressure Support Ventilation (PSV). This system is now commercially available as SmartCare/PS (Draeger Medical AG \& Co. KG, Luebeck, Germany).

The purpose of the study on hand was to find out whether the results reported before could be repeated in a broad, surgical ICU patient group. Study design was chosen similar. In addition we investigated the workload for physicians and nurses in both study arms which has not been conducted before.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms Musculoskeletal Diseases Digestive System Diseases Respiratory Tract Diseases Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AW

Patients received computer-driven protocolized weaning (= Automated Weaning)

Group Type ACTIVE_COMPARATOR

SmartCare/PS (Automated Weaning)

Intervention Type DEVICE

Patients received computer-driven protocolized weaning

CW

Patients received physician-directed non-protocolized weaning (= Conventional Weaning)

Group Type ACTIVE_COMPARATOR

Conventional weaning

Intervention Type PROCEDURE

Patients received physician-directed non-protocolized weaning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SmartCare/PS (Automated Weaning)

Patients received computer-driven protocolized weaning

Intervention Type DEVICE

Conventional weaning

Patients received physician-directed non-protocolized weaning

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SmartCare/PS (Draeger Medical AG & Co. KG, Luebeck, Germany)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* mechanical ventilation \> 24 hours
* intubation OR tracheostomy
* informed consent
* 35 - 200 kg bodyweight (77,2 - 440,9 lb)
* Ramsay-Score \< 3
* spontaneous breathing at a PEEP of \< 10 cm H2O
* sufficient arterial oxygenation (paO2 \> 55 mmHg or SaO2 \> 90%)
* haemodynamic stability (\< 5 µg/kg/min Dopamine)
* body temperature (rectal) max. 39 °C / 102.2 °F
* hemoglobin \> 7 g/dl
* pH \> 7,2
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Luebeck

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Surgery and Surgical Intensive Care

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elke Muhl, Prof. Dr. med.

Role: PRINCIPAL_INVESTIGATOR

University of Luebeck

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UKSH Campus Luebeck, Department of Surgery and Surgical Intensive Care

Lübeck, Schleswig-Holstein, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Lellouche F, Mancebo J, Jolliet P, Roeseler J, Schortgen F, Dojat M, Cabello B, Bouadma L, Rodriguez P, Maggiore S, Reynaert M, Mersmann S, Brochard L. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006 Oct 15;174(8):894-900. doi: 10.1164/rccm.200511-1780OC. Epub 2006 Jul 13.

Reference Type BACKGROUND
PMID: 16840741 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Luebeck 0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.